Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 4/20 | 0.49 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 3/20 | 0.40 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.40 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 4/20 | 0.38 |
| ▸ | CTSL | P07711 | 2/20 | 0.38 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7412904 | 0.80 | SLC7A5 (0.50) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL7412900 | 0.80 | SLC7A5 (0.50) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| Hydrochloric Acid SCHEMBL7384486 | 0.78 | SLC7A5 (0.48) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL27532729 | 0.77 | SLC7A5 (0.47) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL3160891 | 0.77 | SLC7A5 (0.47) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL5525487 | 0.76 | CTSS (0.62) | CTSSCTSKCTSLCTSB | |
| SCHEMBL14283749 | 0.76 | CTSS (0.62) | CTSCCTSSCTSKCTSLCTSB | |
| SCHEMBL13571315 | 0.75 | CTSS (0.43) | CTSCCTSSCTSKDPP4CTSL | |
| SCHEMBL24155348 | 0.75 | SLC7A5 (0.45) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL29981834 | 0.75 | SLC7A5 (0.50) | CTSSSLC7A5CTSKANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110806-A1 | Dipeptide derivatives | ALTMANN EVA (CH) | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110806-A1 | Dipeptide derivatives | CTSL, CTSZ, CTSS | CTSC 9/4885CTSS 3/4885SLC7A5 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.